{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:51:28Z","timestamp":1791899488984,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"North Khorasan University of Medical Sciences","award":["4000220"],"award-info":[{"award-number":["4000220"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11686-024-00962-4","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T13:55:49Z","timestamp":1737726949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Potential Role of Toxoplasma gondii Infection in Multiple Sclerosis Development: A Seroepidemiological Study in North Khorasan Province, Iran"],"prefix":"10.1007","volume":"70","author":[{"given":"Amirali","family":"Ghahremani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-5440","authenticated-orcid":false,"given":"Hasan Namdar","family":"Ahmadabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"javadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"shafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"8","key":"962_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","volume":"19","author":"C Lubetzki","year":"2020","unstructured":"Lubetzki C, Zalc B, Williams A, Stadelmann C, Stankoff B (2020) Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol 19(8):678\u2013688","journal-title":"Lancet Neurol"},{"issue":"12","key":"962_CR2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield KE, Jensen LT, Kaufmann M, Friese MA, Fugger L (2022) The immunology of multiple sclerosis. Nat Rev Immunol 22(12):734\u2013750","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"962_CR3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS. Multiple Scler J 26(14):1816\u20131821","journal-title":"Multiple Scler J"},{"issue":"8","key":"962_CR4","doi-asserted-by":"publisher","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA (2024) Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine 103(8):e37297","journal-title":"Medicine"},{"issue":"4","key":"962_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1352458519872664","volume":"26","author":"L Belbasis","year":"2020","unstructured":"Belbasis L, Bellou V, Evangelou E, Tzoulaki I (2020) Environmental factors and risk of multiple sclerosis: findings from meta-analyses and mendelian randomization studies. Multiple Scler J 26(4):397\u2013404","journal-title":"Multiple Scler J"},{"issue":"12","key":"962_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/14737175.2021.1978843","volume":"21","author":"A Zarghami","year":"2021","unstructured":"Zarghami A, Li Y, Claflin SB, van der Mei I, Taylor BV (2021) Role of environmental factors in multiple sclerosis. Expert Rev Neurother 21(12):1389\u20131408","journal-title":"Expert Rev Neurother"},{"issue":"1\u20132","key":"962_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jneuroim.2011.01.002","volume":"233","author":"J Correale","year":"2011","unstructured":"Correale J, Farez MF (2011) The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 233(1\u20132):6\u201311","journal-title":"J Neuroimmunol"},{"issue":"11","key":"962_CR8","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/pathogens10111351","volume":"10","author":"D Daher","year":"2021","unstructured":"Daher D, Shaghlil A, Sobh E, Hamie M, Hassan ME, Moumneh MB et al (2021) Comprehensive overview of Toxoplasma Gondii-induced and associated diseases. Pathogens 10(11):1351","journal-title":"Pathogens"},{"key":"962_CR9","doi-asserted-by":"publisher","first-page":"106432","DOI":"10.1016\/j.actatropica.2022.106432","volume":"231","author":"RAM de Barros","year":"2022","unstructured":"de Barros RAM, Torrecilhas AC, Marciano MAM, Mazuz ML, Pereira-Chioccola VL, Fux B (2022) Toxoplasmosis in human and animals around the world. Diagnosis and perspectives in the one health approach. Acta Trop 231:106432","journal-title":"Acta Trop"},{"key":"962_CR10","doi-asserted-by":"publisher","first-page":"e00037","DOI":"10.1016\/j.fawpar.2019.e00037","volume":"15","author":"S Stelzer","year":"2019","unstructured":"Stelzer S, Basso W, Silv\u00e1n JB, Ortega-Mora LM, Maksimov P, Gethmann J et al (2019) Toxoplasma Gondii infection and toxoplasmosis in farm animals: risk factors and economic impact. Food Waterborne Parasitol 15:e00037","journal-title":"Food Waterborne Parasitol"},{"key":"962_CR11","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00436-018-6040-2","volume":"117","author":"VO Martinez","year":"2018","unstructured":"Martinez VO, de Mendon\u00e7a Lima FW, De Carvalho CF, Menezes-Filho JA (2018) Toxoplasma Gondii infection and behavioral outcomes in humans: a systematic review. Parasitol Res 117:3059\u20133065","journal-title":"Parasitol Res"},{"key":"962_CR12","doi-asserted-by":"crossref","unstructured":"Rahnama M, Asgari Q, Petramfar P, Tasa D, Hemati V, Solgi R (2020) The role of Toxoplasma Gondii infection among multiple sclerosis patient compared to ordinary people in south of Iran: a case-control study. Mod Care J.;17(3)","DOI":"10.5812\/modernc.105090"},{"issue":"2","key":"962_CR13","first-page":"165","volume":"18","author":"M Shahra","year":"2023","unstructured":"Shahra M, Keshavarz H, Sahraeian MA, Shojaee S, Heidari A, Alimi R et al (2023) Associations between Toxoplasma gondii infection and multiple sclerosis: a case-control seroprevalence study. Iran J Parasitol 18(2):165","journal-title":"Iran J Parasitol"},{"key":"962_CR14","doi-asserted-by":"crossref","unstructured":"Oru\u00e7 S, Karakaya F, Demirbas H, \u00c7e\u00e7en \u0130, K\u00fcsbeci \u00d6Y, Yaman M et al (2016) Relationship of Toxoplasma Gondii exposure with multiple sclerosis. Eur J Gen Med.;13(1)","DOI":"10.15197\/ejgm.01429"},{"issue":"12","key":"962_CR15","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1111\/ene.15055","volume":"28","author":"CE Cicero","year":"2021","unstructured":"Cicero CE, Allibrio FE, Giuliano L, Luna J, Preux PM, Nicoletti A (2021) Toxoplasma Gondii and multiple sclerosis: a systematic review and meta-analysis. Eur J Neurol 28(12):4251\u20134257","journal-title":"Eur J Neurol"},{"issue":"1","key":"962_CR16","doi-asserted-by":"publisher","first-page":"11015","DOI":"10.1038\/s41598-024-61714-y","volume":"14","author":"A Pawe\u0142czyk","year":"2024","unstructured":"Pawe\u0142czyk A, Donskow-\u0141ysoniewska K, Szewczak L, Kierasi\u0144ska M, Machci\u0144ska M, Rola R et al (2024) Seroprevalence of Toxoplasma Gondii and Borrelia burgdorferi infections in patients with multiple sclerosis in Poland. Sci Rep 14(1):11015","journal-title":"Sci Rep"},{"issue":"1","key":"962_CR17","doi-asserted-by":"publisher","first-page":"18855","DOI":"10.1038\/s41598-020-75830-y","volume":"10","author":"A Nicoletti","year":"2020","unstructured":"Nicoletti A, Cicero CE, Giuliano L, Todaro V, Lo Fermo S, Chisari C et al (2020) Toxoplasma Gondii and multiple sclerosis: a population-based case\u2013control study. Sci Rep 10(1):18855","journal-title":"Sci Rep"},{"issue":"12","key":"962_CR18","first-page":"1578","volume":"5","author":"N Pestehchian","year":"2014","unstructured":"Pestehchian N, Etemadifarr M, Yousefi H-A, Chiani M, Aslani N, Nasr Z (2014) Frequency of blood-tissue parasitic infections in patients with multiple sclerosis, as compared to their family members. Int J Prev Med 5(12):1578","journal-title":"Int J Prev Med"},{"key":"962_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jneuroim.2015.05.011","volume":"285","author":"F Stascheit","year":"2015","unstructured":"Stascheit F, Paul F, Harms L, Rosche B (2015) Toxoplasma Gondii seropositivity is negatively associated with multiple sclerosis. J Neuroimmunol 285:119\u2013124","journal-title":"J Neuroimmunol"},{"issue":"4","key":"962_CR20","first-page":"66","volume":"2","author":"H Choobdarian","year":"2019","unstructured":"Choobdarian H, Khadem Erfan MB, Zamini G, Foroutan P, Faridi A, Javan K et al (2019) Comparison of serum level of toxoplasma gondii antibody between patients with multiple sclerosis and healthy people. Int J Biomed Public Health 2(4):66\u201368","journal-title":"Int J Biomed Public Health"},{"key":"962_CR21","unstructured":"Keighobadi M, Alokandeh ND, Baghbanian SM, Karimi N (2021) The role of Toxoplasma Gondii in multiple sclerosis: a matched case-control study. Neurol Asia. 26(2)"},{"issue":"2","key":"962_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1556\/1886.2019.00020","volume":"10","author":"EM M\u00e9ndez-Hern\u00e1ndez","year":"2020","unstructured":"M\u00e9ndez-Hern\u00e1ndez EM, Hern\u00e1ndez-Tinoco J, Salas-Pacheco JM, S\u00e1nchez-Anguiano LF, Arias-Carri\u00f3n O, Sandoval-Carrillo AA et al (2020) Toxoplasma Gondii infection and multiple sclerosis: an age-and a gender-matched case-control seroprevalence study. Eur J Microbiol Immunol 10(2):76\u201379","journal-title":"Eur J Microbiol Immunol"},{"key":"962_CR23","doi-asserted-by":"publisher","first-page":"104871","DOI":"10.1016\/j.msard.2023.104871","volume":"78","author":"G Sevimligul","year":"2023","unstructured":"Sevimligul G, Polat ZA, Gokce SF (2023) Toxoplasma Gondii and multiple sclerosis: a population-based case-control seroprevalence study, Central Anatolia, Turkey. Multiple Scler Relat Disorders 78:104871","journal-title":"Multiple Scler Relat Disorders"},{"issue":"3","key":"962_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1189\/jlb.0709517","volume":"87","author":"P Sfriso","year":"2010","unstructured":"Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N et al (2010) Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 87(3):385\u2013395","journal-title":"J Leukoc Biol"},{"issue":"2","key":"962_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"key":"962_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2018.06.011","volume":"322","author":"R Saberi","year":"2018","unstructured":"Saberi R, Sharif M, Sarvi S, Aghayan SA, Hosseini SA, Anvari D et al (2018) Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. J Neuroimmunol 322:57\u201362","journal-title":"J Neuroimmunol"},{"issue":"11","key":"962_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/trstmh\/trac053","volume":"116","author":"A Rostami","year":"2022","unstructured":"Rostami A, Riahi SM, Mollalo A, Razavian I, Akbari N, Marhoommirzabak E et al (2022) Does latent Toxoplasma infection have a protective effect against developing multiple sclerosis? Evidence from an updated meta-analysis. Trans R Soc Trop Med Hyg 116(11):996\u20131006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"962_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.msard.2017.04.004","volume":"15","author":"A Koskderelioglu","year":"2017","unstructured":"Koskderelioglu A, Afsar I, Pektas B, Gedizlioglu M (2017) Is Toxoplasma gondii infection protective against multiple sclerosis risk? Multiple Scler Relat Disorders 15:7\u201310","journal-title":"Multiple Scler Relat Disorders"},{"key":"962_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s15010-017-1111-3","volume":"46","author":"A Rostami","year":"2018","unstructured":"Rostami A, Karanis P, Fallahi S (2018) Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma Gondii infection. Infection 46:303\u2013315","journal-title":"Infection"},{"key":"962_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s13760-018-0976-y","volume":"118","author":"A Saberi","year":"2018","unstructured":"Saberi A, Akhondzadeh S, Kazemi S (2018) Infectious agents and different course of multiple sclerosis: a systematic review. Acta Neurol Belgica 118:361\u2013377","journal-title":"Acta Neurol Belgica"},{"key":"962_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.29252\/jnkums.5.2.405","volume":"5","author":"F Ali-Asghari","year":"2013","unstructured":"Ali-Asghari F, Shahri L, Besharati R, Arzamani K, Reaghi S (2013) Frequency of IgG and IgM against Toxoplasma Gondii in female students of North Khorasan University of Medical Sciences 2012\u20132013. JNKUMS 5:405\u2013409","journal-title":"JNKUMS"},{"key":"962_CR32","unstructured":"Shafiei R, Shakeri HS (2023) Seroprevalence of Toxoplasma gondii and Vitamin D3 Concentration among School Children 7\u201318 Years Old in Bojnurd City"},{"issue":"8","key":"962_CR33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/jir.13041","volume":"67","author":"M Omidian","year":"2023","unstructured":"Omidian M, Shahrbabak F, Pouryousef A, Turki H, Sarkari B (2023) Seroprevalence of toxoplasmosis among individuals with intellectual disability in Hormozgan Province, southern Iran. J Intellect Disabil Res 67(8):746\u2013752","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"962_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Dard\u00e9 M-L (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25(2):264\u2013296","journal-title":"Clin Microbiol Rev"},{"key":"962_CR35","doi-asserted-by":"publisher","first-page":"1073278","DOI":"10.3389\/fpubh.2023.1073278","volume":"11","author":"Z Qian","year":"2023","unstructured":"Qian Z, Li Y, Guan Z, Guo P, Zheng K, Du Y et al (2023) Global, regional, and national burden of multiple sclerosis from 1990 to 2019: findings of global burden of disease study 2019. Front Public Health 11:1073278","journal-title":"Front Public Health"},{"key":"962_CR36","first-page":"111","volume":"8","author":"SCM Ferreira","year":"2019","unstructured":"Ferreira SCM, Torelli F, Klein S, Fyumagwa R, Karesh WB, Hofer H et al (2019) Evidence of high exposure to Toxoplasma Gondii in free-ranging and captive African carnivores. Int J Parasitology: Parasites Wildl 8:111\u2013117","journal-title":"Int J Parasitology: Parasites Wildl"},{"key":"962_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00313357","volume":"211","author":"P Delmotte","year":"1976","unstructured":"Delmotte P, Demonty L (1976) Biochemical findings in multiple sclerosis: II. A detailed study of the serum IgA, IgG and IgM levels of 772 MS patients compared with 226 neurological controls. J Neurol 211:135\u2013142","journal-title":"J Neurol"},{"issue":"1\u20132","key":"962_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jns.2009.09.016","volume":"288","author":"F Di Pauli","year":"2010","unstructured":"Di Pauli F, Gredler V, Kuenz B, Lutterotti A, Ehling R, Gneiss C et al (2010) Features of intrathecal immunoglobulins in patients with multiple sclerosis. J Neurol Sci 288(1\u20132):147\u2013150","journal-title":"J Neurol Sci"},{"issue":"6","key":"962_CR39","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archneur.1971.00490060060006","volume":"25","author":"M Fischer-Williams","year":"1971","unstructured":"Fischer-Williams M, Roberts RC (1971) Cerebrospinal fluid proteins and serum immunoglobulins: occurrence in multiple sclerosis and other neurological diseases: comparative measurement of \u03c5-Globulin and the IgG class. Arch Neurol 25(6):526\u2013534","journal-title":"Arch Neurol"},{"key":"962_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s40588-019-0114-5","volume":"6","author":"IA Khan","year":"2019","unstructured":"Khan IA, Ouellette C, Chen K, Moretto M (2019) Toxoplasma: immunity and pathogenesis. Curr Clin Microbiol Rep 6:44\u201350","journal-title":"Curr Clin Microbiol Rep"},{"key":"962_CR41","doi-asserted-by":"publisher","first-page":"039463202210784","DOI":"10.1177\/03946320221078436","volume":"36","author":"M Sana","year":"2022","unstructured":"Sana M, Rashid M, Rashid I, Akbar H, Gomez-Marin JE, Dimier-Poisson I (2022) Immune response against toxoplasmosis\u2014some recent updates RH: Toxoplasma Gondii immune response. Int J ImmunoPathol Pharmacol 36:03946320221078436","journal-title":"Int J ImmunoPathol Pharmacol"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00962-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-024-00962-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00962-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:21:54Z","timestamp":1741350114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-024-00962-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1007\/s11686-024-00962-4","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study included human participants. Therefore, written informed consents were obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"32"}}